Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

134 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
134 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

CLI Responds to Calls to Drop “14-Day Limit” on Growing Human Embryos

Human embryos should not be grown for research, manipulated like mice in a lab, or used instrumentally at all. Those who care about the sanctity of life support a zero-day limit that will preserve respect for every human life and refrain from exploitation of or injury to human subjects.

charlotte-lozier-institute Charlotte Lozier Institute
March 18, 2021
ClosePlease login
featured-image
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of David A. Prentice, Ph.D. in Support of Prohibiting Prenatal Discrimination

On March 17, 2021, the Arizona House Judiciary Committee held a hearing on SB 1457, a bill to prohibit prenatal discrimination. Charlotte Lozier Institute’s Vice President and Research Director David A. Prentice, Ph.D., was invited by Senator Nancy Barto to testify as an expert witness, and submitted the following testimony.

featured-image
Fetal Tissue, Stem Cells & Bioethics

CLI Statement on Johnson & Johnson Vaccine: Abortion-Derived Cell Lines Used in Production Process

“For many Americans, the approval of Johnson & Johnson’s vaccine raises renewed questions about the use of cells derived from elective abortions. Many leading vaccine candidates supported by Operation Warp Speed, including the approved vaccines produced by Pfizer/BioNTech and Moderna, do not use abortion-derived cell lines in their production. Unlike the majority of those candidates, Johnson & Johnson does use these cell lines in the production process.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Cell Lines Used for Viral Vaccine Production

Vaccines Licensed for Use in the United States by the Food and Drug Administration (FDA)

Fetal Tissue, Stem Cells & Bioethics

What you need to know about the COVID-19 vaccines

CLI’s analysis found that a majority of vaccine candidates did not use abortion-derived cell lines in their production. Several used abortion-derived cell lines in laboratory testing, or their use in testing could not be determined. Experts urge all vaccine developers to use noncontroversial alternatives.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Análisis del Instituto Charlotte Lozier (CLI): La mayoría de las vacunas de la Operation Warp Speed no se producen usando células derivadas de abortos

El análisis de CLI encontró que la mayoría de las candidatas a vacunas no utilizaban líneas celulares derivadas de abortos en su producción.  Varios utilizaron líneas celulares derivadas del aborto en pruebas de laboratorio, o bien su uso no pudo determinarse en las pruebas.

Fetal Tissue, Stem Cells & Bioethics

CLI Analysis: Majority of Operation Warp Speed Vaccines Not Produced Using Abortion-Derived Cells

“CLI’s expert scientific analysis finds that many leading vaccine candidates supported by Operation Warp Speed do not use abortion-derived cell lines in their production. This is encouraging news.

featured-image
Fetal Tissue, Stem Cells & Bioethics

COVID-19, Nursing Homes, and the Need to Protect the Elderly

In early 2020 news began circulating that a life-threatening respiratory illness was sweeping across the world and had made its way to the United States. Reactions to the severity of the problem varied, but most jurisdictions seemed underprepared to deal with how COVID-19 would impact long-term care facilities, specifically nursing homes.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image